MRI质子密度脂肪分数在肝脂肪变性中的评估:系统综述与Meta分析
该系统综述与Meta分析纳入22项研究共2844例患者,比较MRI-PDFF与肝活检对MASLD肝脂肪变性的分级效能。MRI-PDFF诊断各分级AUC为0.91-0.97,敏感度0.76-0.93、特异度0.89-0.93;提示5.7%阈值可能用于区分0级与≥1级。结论认为MRI-PDFF精确无创,但需进一步研究确立诊断阈值。
要点
- MRI-PDFF区分0级与≥1级脂肪变的AUC为0.97(95%CI 0.96-0.98)。
- 随脂肪变分级升高,MRI-PDFF诊断准确度下降(≤2 vs 3的AUC为0.91)。
- 5.7%阈值可能用于区分无脂肪变与脂肪变(p=0.075)。
核心结论
- MRI-PDFF是诊断和分级肝脂肪变性的精确无创技术,需进一步研究确立其诊断阈值。
- 本研究强调MRI-PDFF区分不同肝脂肪变分级具有高诊断准确度,但更广泛应用仍需进一步研究。
- MRI-PDFF为肝脂肪变的诊断和监测提供精确性。
- MRI-PDFF的诊断准确度随肝脂肪变分级升高而下降。
- 5.7%的MRI-PDFF阈值可区分脂肪肝与非脂肪肝。
研究设计与样本
- 系统综述与Meta分析,检索Embase、PubMed/Medline、Scopus和Web of Science截至2024年1月13日。
- 纳入22项比较MRI-PDFF与肝活检对肝脂肪变性分级的研究,共2844例患者。
- 肝脂肪变性分级定义为0级(脂肪变<5%)、1级(5-33%)、2级(34-66%)、3级(>66%)。
诊断标准与关键数值
- 0级 vs ≥1级:AUC 0.97(95%CI 0.96-0.98)。
- ≤1级 vs ≥2级:AUC 0.91(95%CI 0.88-0.93)。
- ≤2级 vs 3级:AUC 0.91(95%CI 0.88-0.93)。
- 诊断比值比(DOR)范围98.74(95%CI 58.61-166.33)至23.36(95%CI 13.76-39.68);敏感度范围0.93(95%CI 0.88-0.96)至0.76(95%CI 0.63-0.85),特异度范围0.93(95%CI 0.88-0.96)至0.89(95%CI 0.84-0.93);LR+范围13.3(95%CI 7.4-24.0)至7.2(95%CI 4.9-10.5),LR-范围0.08(95%CI 0.05-0.13)至0.27(95%CI 0.17-0.42)。
- 提出的MRI-PDFF肝脏脂肪含量阈值5.7%可能作为区分0级 vs ≥1级的cut-off(p=0.075)。
局限性
- 原文结论提出需进一步研究以确立MRI-PDFF的诊断阈值。
- 原文临床相关性声明指出更广泛应用仍需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Amidst the global rise of metabolic dysfunction-associated steatotic liver disease (MASLD), driven by increasing obesity rates, there is a pressing need for precise, non-invasive diagnostic tools. Our research aims to validate MRI Proton Density Fat Fraction (MRI-PDFF) utility, compared to liver biopsy, in grading hepatic steatosis in MASLD.
METHODS: A systematic search was conducted across Embase, PubMed/Medline, Scopus, and Web of Science until January 13, 2024, selecting studies that compare MRI-PDFF with liver biopsy for hepatic steatosis grading, defined as grades 0 (< 5% steatosis), 1 (5-33% steatosis), 2 (34-66% steatosis), and 3 (> 66% steatosis).
RESULTS: Twenty-two studies with 2844 patients were included. The analysis showed high accuracy of MRI-PDFF with AUCs of 0.97 (95% CI = 0.96-0.98) for grade 0 vs ≥ 1, 0.91 (95% CI = 0.88-0.93) for ≤ 1 vs ≥ 2, and 0.91 (95% CI = 0.88-0.93) for ≤ 2 vs 3, diagnostic odds ratio (DOR) from 98.74 (95% CI = 58.61-166.33) to 23.36 (95% CI = 13.76-39.68), sensitivity and specificity from 0.93 (95% CI = 0.88-0.96) to 0.76 (95% CI = 0.63-0.85) and 0.93 (95% CI = 0.88-0.96) to 0.89 (95% CI = 0.84-0.93), respectively. Likelihood ratio (LR) + ranged from 13.3 (95% CI = 7.4-24.0) to 7.2 (95% CI = 4.9-10.5), and LR - from 0.08 (95% CI = 0.05-0.13) to 0.27 (95% CI = 0.17-0.42). The proposed MRI-PDFF threshold of 5.7% for liver fat content emerges as a potential cut-off for the discrimination between grade 0 vs ≥ 1 (p = 0.075).
CONCLUSION: MRI-PDFF is a precise non-invasive technique for diagnosing and grading hepatic steatosis, warranting further studies to establish its diagnostic thresholds.
CLINICAL RELEVANCE STATEMENT: This study underscores the high diagnostic accuracy of MRI-PDFF for distinguishing between various grades of hepatic steatosis for early detection and management of MASLD, though further research is necessary for broader application.
KEY POINTS: MRI-PDFF offers precision in diagnosing and monitoring hepatic steatosis. The diagnostic accuracy of MRI-PDFF decreases as the grade of hepatic steatosis advances. A 5.7% MRI-PDFF threshold differentiates steatotic from non-steatotic livers.
引用
- Azizi N, Naghibi H, Shakiba M, et al. Evaluation of MRI proton density fat fraction in hepatic steatosis: a systematic review and meta-analysis. Eur Radiol. 2024. PMID: 39254718. doi:10.1007/s00330-024-11001-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。